Molecular Mechanism of Action of Genistein and Related Phytoestrogens in Estrogen Receptor Dependent and Independent Growth of Breast Cancer Cells

Abstract

Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions tor reducing this burden to Washington Headquarters Services, Directorate for Information Operations and Reports. 1215 Jefferson Davis Highway, Suite 1204, Arlington. VA 22202-4302, and AUTHOR(S)Srivani Balabhadrapathruni T. Thomas During the 3 years of my pre-doctoral research supported by the U.S. Army's Breast Cancer Research Program, I studied estrogen receptor (ER)-dependent and -independent effects of five structurally related phytoestrogens on breast cancer cell growth and apoptosis. Our studies showed that genistein binds to the ER with lower affinity compared to estradiol. However, genistein-bound ER is a 4S monomeric protein, while estradiol-bound ER is multimeric in our sucrose density gradient experiments. We also showed that genistein-ERß complex bound to the consensus estrogen responsive element (ERE) with high affinity. In contrast, genistein bound to ERoc did not significantly bind to the ERE. These results suggest that genistein and estradiol exert different effects on ER-mediated functions. FUNDING NUMBERS DAMD17-97-1-7035 PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES)UniversityIn ER-negative cells, genistein and quercetin inhibited cell growth and induced apoptosis in a dosedependent manner. Daidzein, kaempferol and biochanin A were less effective. The mechanism of growth inhibition in ER-positive and ER-negative breast cancer cells by genistein and quercetin included G2/M cell cycle arrest and alterations in cyclin Bl protein. Our results suggest that genistein and quercetin may be developed as chemotherapeutic agents against treatment of ER-negative tumors. 4>h Where copyrighted material is quoted, permission has been obtained to use such material. SUBJECT TERMS Breast Cancer NUMBER OF PAGES 62 PRICE CODEM?j> where material from documents designated for limited distribution is quoted, permission has been obtained to use the material.rMfr Citations of commercial organizations and trade names in this report do not constitute an official Department of Army endorsement or approval of the products or services of these organizations.N/A In conducting research using animals, the investigator(s) adhered to the "Guide for the Care and Use of Laboratory Animals," prepared by the Committee on Care and use of Laboratory Animals of the Institute of Laboratory Resources, national Research Council (NIH Publication No. 86-23, Revised 1985).iK For the protection of human subjects, the investigator(s) adhered to policies of applicable Federal Law 45 CFR 46.N/A In conducting research utilizing recombinant DNA technology, the investigator(s) adhered to current guidelines promulgated by the National Inst...